Get the Stockscreener App
0.1896
1.20%
-0.0023
After Hours:
.20
0.0104
+5.49%
Processa Pharmaceuticals Inc stock is traded at $0.1896, with a volume of 2.35M.
It is down -1.20% in the last 24 hours and down -14.09% over the past month.
Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).
See More
Previous Close:
$0.1919
Open:
$0.18
24h Volume:
2.35M
Relative Volume:
0.14
Market Cap:
$9.55M
Revenue:
-
Net Income/Loss:
$-11.53M
P/E Ratio:
-0.0393
EPS:
-4.82
Net Cash Flow:
$-11.12M
1W Performance:
+10.36%
1M Performance:
-14.09%
6M Performance:
-57.97%
1Y Performance:
-85.85%
1-Day Range:
$0.18
$0.1934
1-Week Range:
$0.1718
$0.203
52-Week Range:
$0.15
$1.50
Processa Pharmaceuticals Inc Stock (PCSA) Company Profile
Name
Processa Pharmaceuticals Inc
Sector
Industry
Phone
443-776-3133
Address
601 21ST STREET, SUITE 300, VERO BEACH
Compare PCSA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PCSA
Processa Pharmaceuticals Inc
|
0.1896 | 9.65M | 0 | -11.53M | -11.12M | -4.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-25-24 | Initiated | H.C. Wainwright | Buy |
Processa Pharmaceuticals Inc Stock (PCSA) Latest News
Processa Pharmaceuticals Reschedules Special Shareholder Meeting - MSN
Reversal Confirmed Processa Pharmaceuticals Inc. Stock Rallies Above MAJuly 2025 Closing Moves & Verified Swing Trading Watchlist - beatles.ru
Visual trend scoring systems applied to Processa Pharmaceuticals Inc.Insider Buying & Comprehensive Market Scan Insights - Newser
Is Processa Pharmaceuticals Inc. trending in predictive chart models2025 Top Gainers & Verified Momentum Stock Alerts - Newser
How high can Processa Pharmaceuticals Inc. stock goJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - Newser
Processa Pharmaceuticals Inc. Hits Price Floor — Bounce IncomingDip Buying & Weekly Watchlist of Top Performers - beatles.ru
Combining machine learning predictions for Processa Pharmaceuticals Inc.Market Movement Recap & Free Weekly Watchlist of Top Performers - Newser
How to forecast Processa Pharmaceuticals Inc. trends using time seriesWeekly Profit Report & Free Weekly Chart Analysis and Trade Guides - Newser
Is it time to cut losses on Processa Pharmaceuticals Inc.Quarterly Profit Review & Real-Time Stock Entry Alerts - Newser
Historical volatility pattern of Processa Pharmaceuticals Inc. visualizedBuy Signal & Community Verified Trade Alerts - Newser
Exit strategy if you’re trapped in Processa Pharmaceuticals Inc.July 2025 Action & Weekly Breakout Watchlists - Newser
Bollinger Bands Show Potential Breakout in Processa Pharmaceuticals Inc.Portfolio Risk Summary & Target Return Focused Picks - beatles.ru
Is Processa Pharmaceuticals Inc. stock bottoming outJuly 2025 Sentiment & Safe Entry Point Alerts - Newser
What’s next for Processa Pharmaceuticals Inc. stock priceWeekly Market Summary & Fast Entry High Yield Tips - Newser
Analyzing drawdowns of Processa Pharmaceuticals Inc. with statistical toolsJuly 2025 Earnings & Safe Swing Trade Setups - Newser
Is Processa Pharmaceuticals Inc. stock poised for growth2025 Earnings Surprises & Capital Efficiency Focused Strategies - Newser
What Fibonacci levels say about Processa Pharmaceuticals Inc. reboundPortfolio Gains Summary & Free Expert Verified Stock Movement Alerts - Newser
How Processa Pharmaceuticals Inc. stock performs during market volatilityWeekly Investment Summary & Technical Pattern Based Signals - Newser
Can Processa Pharmaceuticals Inc. sustain earnings growthJuly 2025 Recap & Weekly Momentum Picks - خودرو بانک
Will Processa Pharmaceuticals Inc. benefit from green energy policiesWeekly Trade Review & Free Risk Controlled Daily Trade Plans - خودرو بانک
Can Processa Pharmaceuticals Inc. sustain its profitabilityWeekly Profit Analysis & Smart Investment Allocation Tips - خودرو بانک
HC Wainwright Has Optimistic Outlook of Heatwurx Q3 Earnings - Defense World
Will Processa Pharmaceuticals Inc. price bounce be sustainableJuly 2025 Institutional & Low Risk Entry Point Tips - Newser
Backtesting results for Processa Pharmaceuticals Inc. trading strategiesWeekly Trend Report & Safe Swing Trade Setups - Newser
Does Processa Pharmaceuticals Inc. qualify in momentum factor screeningWeekly Trend Report & Accurate Intraday Trading Signals - Newser
Applying Elliott Wave Theory to Processa Pharmaceuticals Inc.July 2025 Catalysts & Entry and Exit Point Strategies - Newser
Is now the right time to enter Processa Pharmaceuticals Inc.Earnings Miss & Precise Entry and Exit Recommendations - خودرو بانک
Dow Update: What drives Processa Pharmaceuticals Inc.’s stock price2025 Key Highlights & Scalable Portfolio Growth Methods - خودرو بانک
What’s the recovery path for long term holders of Processa Pharmaceuticals Inc.Weekly Market Report & Comprehensive Market Scan Reports - Newser
Institutional scanner results for Processa Pharmaceuticals Inc.2025 Macro Impact & Consistent Income Trade Ideas - Newser
Full technical analysis of Processa Pharmaceuticals Inc. stockPortfolio Risk Summary & Safe Capital Allocation Plans - Newser
Is Processa Pharmaceuticals Inc.’s ROE strong enoughMarket Sentiment Summary & AI Enhanced Trading Signals - خودرو بانک
Published on: 2025-09-03 03:51:14 - Newser
Can Processa Pharmaceuticals Inc. maintain its current growth rate2025 Historical Comparison & AI Forecast Swing Trade Picks - خودرو بانک
Sentiment analysis tools applied to Processa Pharmaceuticals Inc.Market Movers & Safe Entry Trade Reports - Newser
Heatwurx (NASDAQ:PCSA) Given New $1.00 Price Target at HC Wainwright - Defense World
Processa Pharmaceuticals Inc. stock retracement – recovery analysisMarket Risk Analysis & Weekly Watchlist of Top Performers - Newser
Processa Pharmaceuticals Adjourns Special Shareholder Meeting - TipRanks
H.C. Wainwright lowers Processa Pharmaceuticals stock price target on dilution - Investing.com Canada
Processa Pharmaceuticals Inc Stock (PCSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):